Oracle · one lens
Robert Shiller on Oracle
Oracle’s AI leasing story has a measurable financing cost, while the record cannot show that the story recruited buyers.
Per the supplied market data, Oracle closed on October 9 at $141.40, up 4.21% from $135.69 the prior session. Shiller’s Irrational Exuberance describes a feedback loop in which a price move invites an explanation, the explanation reaches new buyers, and their demand supports the price. CNBC reported that Oracle and other AI stocks had fallen after a report challenged OpenAI’s previously reported September-end annualized revenue. Oracle’s daily gain does not show why buyers acted. The coverage records a story and a price move, not the link between them.
Oracle gives Shiller’s new-era thinking test a concrete question: are investors treating future AI capacity as if it had already produced cash? Per the company dossier, the Wall Street Journal reported an OpenAI computing contract worth $300 billion over roughly five years, with capacity starting in 2027. Oracle spent $55.7 billion on capital expenditure in fiscal 2026, compared with $21.2 billion in fiscal 2025. The dossier puts fiscal 2026 free cash flow at negative $23.7 billion, compared with negative $394 million in fiscal 2025, and total debt at $156.2 billion, compared with $104.1 billion a year earlier. Those figures establish the present cost of the buildout; they do not settle what the contract will earn.
TEXXR counted 27 Oracle articles in the completed third quarter of 2026, against a reported average of 20 per quarter over the preceding eight quarters. The record measures increased coverage, not increased demand or completed capacity. The Wall Street Journal reported power and permitting hurdles at Oracle’s Project Jupiter in New Mexico. Its later report described talks to finance a large chip purchase, not completed financing. Both reports give the coverage something firmer to test than a price-led explanation.
Oracle has signed demand and an immediate funding burden. The TEXXR record has no buyer-belief survey, demonstrated price-to-news-to-buyer sequence, or cyclically adjusted valuation baseline for Shiller’s stronger speculative-epidemic test. Oracle’s financing and power constraints matter even if that feedback loop never takes hold.
An editorial application of Robert Shiller's published framework — not their actual view, affiliation, or advice.
Where this lens comes from
Robert Shiller's framework is set out at the lens page, drawn from Irrational Exuberance. This page applies it to Oracle and nothing else — the company's full record is in the dossier.